Plaque Inhibitory Effect of Neutral Electrolysed Water in the Form of a Mouthwash in a 4-day Non-brushing Model
Evaluation of a Mouthwash Formulation Containing Neutral Electrolysed Water on De-novo Plaque Formation, Gingival Inflammation, MMP-8 Activity and the Oral Microbiome
1 other identifier
interventional
16
1 country
1
Brief Summary
Electrolysed water (EOW) is produced by the electrolysis of sodium chloride in an aqueous solution, producing chlorine gas at the anode and sodium hydroxide and hydrogen at the cathode. EOW is known to have antimicrobial effects against various microorganisms, including viruses, bacteria, spores and fungi. Its antimicrobial activity is generally attributed to its hypochloric acid content - a product of chlorine gas dissolved in water. Due to its biocompatibility, known uses of EOW include ocular disinfection, nasal irrigation and chronic cutaneous wound care. In the dental setting, it may be used as a mouthwash, disinfectant, irrigant, mouthwash or dental gel. The aim of this study is to investigate the effect of a mouthwash containing neutral electrolyzed water on plaque accumulation (evaluated using a disclosing agent and an intraoral scanner), gingival inflammation, MMP-8 activity and the oral microbiome. In this double-blind, cross-over, 4-day experimental gingivitis model, each subject will participate in all three arms of the study. Each arm will last 4 days, during which the subjects will be asked to refrain from toothbrushing and the use of interdental cleaning devices. Instead, they will be instructed to rinse their oral cavities twice daily with either EOW, placebo or a positive control (chlorhexidine), according to a randomisation chart (each subject will receive a different mouthwash type in every arm of the study). The outcomes will be assessed at baseline and after 4 days. A washout period of at least 7 days will be implemented between each study arm.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started Jan 2023
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 5, 2023
CompletedFirst Submitted
Initial submission to the registry
January 23, 2023
CompletedFirst Posted
Study publicly available on registry
February 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 21, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 21, 2023
CompletedJuly 13, 2023
January 1, 2023
2 months
January 23, 2023
July 12, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
3D plaque score
Differences in plaque scores evaluated by optical scanning
baseline, 4 days
Plaque index
Differences on plaque score evaluated using the Turesky Modification of the Quigley-Hein Plaque Index
baseline, 4 days
Secondary Outcomes (3)
Modified Gingival Index
baseline, 4 days
Microbiologic profile of gingival crevicular fluid
baseline, 4 days
MMP-8 in gingival crevicular fluid
baseline, 4 days
Study Arms (3)
1
OTHERBased on a randomisation table, each participant will use either a mouthwash containing neutral electrolyzed water, placebo, or chlorhexidine digluconate twice a day instead of tooth brushing and flossing for 4 days. Each subject will receive each mouthwash type only once during the study period (he/she will receive a different mouthwash type in every arm of the study based on a randomisation table).
2
OTHERBased on a randomisation table, each participant will use either a mouthwash containing neutral electrolyzed water, placebo, or chlorhexidine digluconate twice a day instead of tooth brushing and flossing for 4 days. Each subject will receive each mouthwash type only once during the study period (he/she will receive a different mouthwash type in every arm of the study based on a randomisation table).
3
OTHERBased on a randomisation table, each participant will use either a mouthwash containing neutral electrolyzed water, placebo, or chlorhexidine digluconate twice a day instead of tooth brushing and flossing for 4 days. Each subject will receive each mouthwash type only once during the study period (he/she will receive a different mouthwash type in every arm of the study based on a randomisation table).
Interventions
Use of mouthwash containing neutral electrolyzed water twice daily for 4 consecutive days instead of tooth brushing and usage of interdental cleaning devices.
Use of mouthwash containing placebo twice daily for 4 consecutive days instead of tooth brushing and usage of interdental cleaning devices.
Use of mouthwash containing chlorhexidine digluconate twice daily for 4 consecutive days instead of tooth brushing and usage of interdental cleaning devices.
Eligibility Criteria
You may qualify if:
- age 20 - 30 years,
- non-smoker,
- systemically healthy,
- without regular systemic medication,
- presence of at least 6 teeth in each jaw quadrant,
- plaque index \< 10 % at baseline visit,
- absence of periodontal pockets measuring \> 4 mm.
You may not qualify if:
- known allergy or suspected hypersensitivity to chlorhexidine digluconate,
- gingivitis,
- regularly use of mouthwash as part of oral hygiene routine,
- antibiotic treatment in the last 6 months or during the observation period,
- pregnancy or lactation,
- fixed or removable prosthetic devices, dental implants.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Ljubljana
Ljubljana, 1000, Slovenia
Related Publications (1)
Povsic K, Munjakovic H, Zayed N, Teughels W, Seme K, Fidler A, Gaspersic R. Electrolyzed saline as an alternative to chlorhexidine: Antimicrobial and biofilm volume outcomes in a 4-day non-brushing randomized controlled clinical trial. J Periodontol. 2026 Feb 2. doi: 10.1002/jper.70070. Online ahead of print.
PMID: 41627021DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 23, 2023
First Posted
February 1, 2023
Study Start
January 5, 2023
Primary Completion
February 21, 2023
Study Completion
June 21, 2023
Last Updated
July 13, 2023
Record last verified: 2023-01